Concepedia

Steffen Pabel

SP

26

Publications

1.7K

Citations

22

H-Index

2015

Active since

Affiliations

University Hospital Regensburg(Current)

German Centre for Cardiovascular Research

University of Göttingen

Heart and Diabetes Center North Rhine-Westphalia

Ruhr University Bochum

Steffen Pabel is an author at University Hospital Regensburg specializing in cardiovascular disease, cardiology, and physiology.

ORCID

Top concepts

Publications per year

2015–2024

26

Publications

26

Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation

Detmar Kolijn, Steffen Pabel, Yanna Tian et al. · Cardiovascular Research · 2020 · 300 citations · Full text

Empagliflozin Reduces Ca/Calmodulin-Dependent Kinase II Activity in Isolated Ventricular Cardiomyocytes

Julian Mustroph, Olivia Wagemann, Charlotte M. Lücht et al. · ESC Heart Failure · 2018 · 229 citations · Full text

Empagliflozin Directly Improves Diastolic Function in Human Heart Failure

Steffen Pabel, Stefan Wagner, Hannah Bollenberg et al. · European Journal of Heart Failure · 2018 · 213 citations · Full text

Recruited macrophages elicit atrial fibrillation

Maarten Hulsmans, Maximilian J. Schloss, I‐Hsiu Lee et al. · Science · 2023 · 182 citations · Full text

Empagliflozin Inhibits Na+/H+ Exchanger Activity in Human Atrial Cardiomyocytes

Maximilian Trum, Johannes Riechel, Simon Lebek et al. · ESC Heart Failure · 2020 · 108 citations · Full text

Rows per page

1–5 of 26